healthcare
Beyond Market Intelligence keeps healthcare in one place: 24 stories so far. The section currently leads with “Even Healthcare secures $300M valuation to reshape India's hospital economics”, “Ultrahuman and Abu Dhabi partner to validate biological-age model over two years”, and “Healthleap secures $38M to help clinicians spot at-risk patients earlier”. India's hospital economics are getting a serious rethink. Two years of clinical validation sounds like the right kind of patience for a model that claims to measure biological age. Acme AI is the next-generation, AI-powered spreadsheet platform built to replace Excel and redefine how analysts, data scientists, and enterprise teams work… The list below is every healthcare story on Beyond Market Intelligence, newest first.
Even Healthcare secures $300M valuation to reshape India's hospital economics
India's hospital economics are getting a serious rethink. Even Healthcare just secured a $300 million valuation in a Khosla Ventures-led round, and its plan to expand its network signals a shift toward more accessible, tech-driven care. This isn't about adding beds; it's about reimagining how hospitals operate. For those following the intersection of technology and real-world infrastructure, our piece on exposed credentials letting rogue AI slip through India's cloud defenses offers a cautionary parallel.
Ultrahuman and Abu Dhabi partner to validate biological-age model over two years
Two years of clinical validation sounds like the right kind of patience for a model that claims to measure biological age. Ultrahuman and Abu Dhabi are committing to real research, not just a flashy launch. That matters. If you are curious about how AI is quietly reshaping other unexpected areas, our piece on AI-powered weather balloons winning a military contract offers a fascinating parallel.
Healthleap secures $38M to help clinicians spot at-risk patients earlier
Healthleap has secured $38 million to help clinicians identify at-risk patients earlier, a critical step toward proactive care. The funding pairs an $8M seed round co-led by Sequoia Capital and First Round Capital with a $30M Series A led by Hummingbird Ventures. That investor confidence signals real momentum for tools that catch deterioration before it becomes a crisis. For a deeper look at how AI is reshaping practical workflows, explore our coverage of ChatGPT's new visual interface.
Wahlberg and Lee to Discuss Investing, Entrepreneurship at Disrupt 2026
Mark Wahlberg isn't just talking about building businesses; he's sitting down with Bruce K. Lee at Disrupt 2026 to show how investing and entrepreneurship intersect with healthcare and wellness. That's a conversation worth your attention. It's easy to separate money from mission, but Wahlberg's track record suggests he sees them as the same equation. Expect practical insight on scaling ventures without losing sight of the human element.
Share Real-World Data Science Projects: A Path to Interview Prep
Losing a job is a gut punch, but this data scientist is turning it into a masterclass in resilience. Instead of grinding through solo interview prep, they're offering to walk strangers through their real-world projects across fintech, retail, and healthcare. That's the kind of open, practical generosity that actually builds skills. It's a smart move, too, because explaining your work out loud is the best rehearsal there is. If you're prepping for a data role, this is a low-pressure way to learn.
AI Biotech Enveda Accelerates Drug Development with $311M Investment
Enveda's $311M raise isn't just a big number; it's a signal that AI-driven drug discovery is moving from promise to pipeline. The $2B valuation reflects real momentum, especially as the company targets skin conditions and tackles the stubborn problem of weight regain after GLP-1s. That's practical science with tangible outcomes. We're watching a biotech that understands the patient's journey, not just the lab bench. For more on who's betting big on emerging tech, check our piece on Wahlberg and Lee's upcoming Disrupt discussion.
AI in Fintech & Healthcare: Understanding Data Flow and Security
A software engineer at a large fintech company raises a question that should give every data professional pause: if AI systems connect directly to sensitive production data, how do you keep that information from leaking into the cloud? And when it does leave, what happens to PII over time? This is the right question to ask. A single slip might seem harmless, but two years of accumulated data becomes a tempting target. The risk isn't hypothetical. It's architectural.
Angle Health proves small business insurance can be both profitable and accessible.
Angle Health, the Y Combinator alum focused on insurance tech, just hit a $2.7B valuation, and the milestone feels earned. The company has grown to 5,000 customers and, more tellingly, reached profitability by helping small businesses navigate level-funded health insurance. That is a practical win in a space where complexity usually wins. It is a clear signal that accessible, human-centered health coverage is not just possible; it is viable.
Evvy secures $40M to advance women's health through microbiome data
Evvy just raised $40 million in a Series B round led by Catalio Capital Management, and that's a meaningful vote of confidence for a company putting vaginal microbiome data at the center of women's health research. It's about time this kind of data got serious backing. The funding can accelerate discoveries that have been underfunded for too long. If you're tracking how capital is moving through health innovation, this pairs well with our coverage on Wahlberg and Lee discussing wellness at Disrupt 2026.
How Thatch helps employers simplify healthcare costs with smarter coverage choices
Thatch just crossed a significant milestone: a $1 billion valuation, and it's easy to see why. As healthcare costs climb, the company is giving employers a practical way to manage expenses by funding individual insurance plans through an ICHRA marketplace. It's a model that prioritizes flexibility over a one-size-fits-all company policy. We're watching this space closely, especially as data-driven decisions reshape benefits. For more on how technology is influencing this sector, our piece on AI in Fintech & Healthcare offers useful context.
Clinicians gain read-only access to patient records through ChatGPT Health integration
OpenAI's new Epic integration for ChatGPT Health gives clinicians read-only access to patient records, a practical step toward reducing friction in care. It's a focused move, not a sweeping promise, and that restraint feels right for a tool handling sensitive data. Clinicians need efficiency, but they also need guardrails. This delivers both. For more on how AI handles sensitive information, our related piece, "AI Agents Shared User Images, Highlighting Data Security Concerns," offers useful context. Explore what this means for your workflow.
Securing patient data demands a smarter approach to risk management.
McKesson, a giant in U.S. healthcare distribution, is facing a stark reality: hackers claim to have stolen millions of patient records. The company confirms the breach and warns of intermittent service degradation. This isn't just a technical glitch; it's a direct challenge to the trust patients place in the systems holding their most sensitive data. We should expect a prolonged recovery, and the ripple effects across hospitals will be felt for some time.
Grindr bets on AI and healthcare to transform into a digital gayborhood
George Arison is done letting Wall Street's "Grindr discount" go unchallenged. In a wide-ranging Q&A, the CEO makes the case that AI, a controversial $350-plus EDGE tier, and bets on healthcare and long-distance matchmaking can transform the app into the "gayborhood in your pocket." It's a bold pitch, and investors are right to question the math. But dismissing it outright ignores how deliberately he's reframing the brand.
Why open data, not moats, will let AI engineer better medicine
Vijay Pande walked away from managing $4 billion at a16z to bet smaller, and that restraint is exactly the point. His new firm, VZVC, leans into AI-native investing because he sees biology shifting from discovery to engineering. Clinical trials remain brutally expensive, and he argues open, shared datasets will matter more than proprietary walls. That conviction feels right. For a deeper look at how AI handles messy real-world data, our piece on real-world computer vision deployments is worth reading.
Boston Scientific cyberattack disrupts global operations, device impact unclear
Boston Scientific is facing a serious test of trust after confirming a cyberattack has thrown its operations into global disruption. The medical device maker hasn't yet said whether patient data was taken or if any devices are compromised, leaving a lot of uncertainty in the air. That silence is concerning for a company people rely on for critical care. When infrastructure this essential gets hit, transparency matters as much as the fix.
Discover how better data unlocks AI's real potential in healthcare.
If AI is going to move the needle on cancer, it won't be through clever algorithms alone. This startup argues the real bottleneck is data, plain and simple. That's a refreshingly grounded take in a field prone to hype. We're not talking about magic; we're talking about feeding models the right, clean information. It's a messier problem than most want to admit, but it's the one that matters.
Neko Health brings AI-driven body scanning to New York, expanding preventive care access
Nelly Health, the body-scanning and bloodwork startup co-founded by Spotify's Daniel Ek, is bringing its health checkups to New York City, with its first US office set to open in about a month. It's a deliberate move into a market where preventive care is ripe for a refresh. For anyone tired of waiting for symptoms to appear, this is a chance to explore a more proactive approach to health data. Curious about the broader wellness investment wave? Mark Wahlberg and Bruce K.
Building trusted AI for regulated industries at global scale
Building production-ready AI in healthcare isn't just about getting the model right, it's about engineering trust from the ground up. Heidi, an Australian-founded AI Care Partner, proves this by automating clinical documentation across 190 countries, handling 2.7 million patient interactions weekly. The company's success rests on infrastructure decisions made years ago, prioritizing data residency, auditability, and safety by default. As CTO Yu Liu puts it, trust is architectural.
From Academia to Impact: Translating Public Health Expertise into Industry
Four years in academia, with publications in JAMA Open and experience in doubly robust methods, gives you a real analytical foundation. That is not the problem. The gap is likely in how you are framing your transition. You are studying SQL and probability, which is good, but you need to show how your causal inference work solves business problems. Frame your research as applied decision-making. Also, revisit that tech internship network; it is your strongest asset.
CareCloud data breach exposes patient records, urging stronger data safeguards
CareCloud is now notifying hundreds of thousands of individuals after hackers breached one of its protected health data stores. The health tech giant, which manages vast amounts of patient medical records, confirmed the intrusion into its systems. This incident underscores a worrying trend in healthcare security, where sensitive data remains a prime target. For a deeper look at how AI agents are exposing user information elsewhere, check out our related piece, "AI Agents Shared User Images, Highlighting Data Security Concerns.
Beyond identity: securing enterprise AI agents for real-world resilience
Shared credentials are a known risk, but at VB Transform 2026, NTT DATA AIVista and Snowflake made the case that fixing identity alone won't secure enterprise AI agents. Mukesh Karki and Mayank Upadhyay argued for action-level authorization and tamper-resistant audit trails built into every interaction. That provability, as Karki put it, is your license to operate. It's a practical framework for scaling autonomous systems safely, and it pairs well with our coverage of recent agentic security incidents.
Explore how AI weaves your health data into smarter personal insights
OpenAI has made ChatGPT Health available to all US users, opening the door to a more personalized data experience. The integration with Apple Health, Function, and MyFitnessPal means your daily metrics can now inform your AI conversations directly. That is a meaningful step toward practical, human-centered data management. If you are exploring how AI handles real-world inputs, our related piece on real-world computer vision deployments offers a useful technical counterpoint.
Cybersecurity breach exposes patient billing data at thousands of U.S. hospitals
Craneware, the Edinburgh-based tech firm trusted by thousands of U.S. hospitals and pharmacies for patient billing, has confirmed that hackers stole a "significant" amount of customer data during a cyberattack. That's a serious breach, especially when the exposed information could touch sensitive health records. It's a stark reminder that the tools we rely on for critical operations are prime targets.
Explore how AI unlocks new discoveries in life sciences funding
Miles Wang, an OpenAI researcher, is reportedly in talks to launch an AI-driven drug discovery startup with a $2 billion valuation. That's a striking signal of where the industry sees the next breakthrough. Investors are betting that AI can tackle the messy, high-stakes work of life sciences, not just automate spreadsheets. It's a bold move, and one that feels overdue. For anyone tracking how AI moves beyond data management into real-world impact, this is worth watching closely.